Study: New Mapping Method Improves Detection of Leukemia Abnormalities
Research shows optical genome mapping identifies genomic changes in nearly 98% of T-cell acute lymphoblastic leukemia cases compared to 55% with traditional analysis.
Tag: next-generation sequencing
All
Latest
All
Latest
Study Validates Next-Generation Sequencing Test for Urinary Tract Infections
Biotia’s clinical study, published in Microbiology Spectrum, validates an NGS and machine learning assay for UTIs, reporting 97.2% sensitivity and 99.6% specificity in direct detection and AMR profiling from urine samples.
All
Latest
New Research on Automated Myeloid Testing and Molecular Residual Disease to be Presented at AACR 2026
Biodesix will present seven abstracts—including two oral sessions—at AACR 2026, highlighting advances in automated myeloid testing, liquid biopsy, and NGS-based cancer monitoring platforms.
SPT Labtech Partners to Develop Automated Genomics Platform for Smaller Labs
The collaboration aims to develop an automated genomics platform for decentralized labs, aiming to expand access to streamlined NGS workflows in oncology.
Read More
Illumina Announces NovaSeq X Performance Upgrades Including Q70 Quality Scores
Illumina has announced an 18-month roadmap for NovaSeq X, featuring a 40% output increase to 35 billion reads, faster turnaround times, new flow cell options, and the introduction of Q70 quality scores.
Read More
Ultima Genomics Partners with Hamilton to Automate NGS Sample Preparation
Ultima Genomics and Hamilton have partnered to automate NGS sample preparation and amplification workflows, integrating Ultima’s sequencing systems with Hamilton’s Microlab STAR liquid handling platform to improve lab efficiency.
Read More
NeoGenomics Launches PanTracer Pro for Solid Tumor Testing
The integrated testing approach combines genomic profiling with immunohistochemistry to support faster treatment decisions for advanced-stage cancer patients.
Read More
Thermo Fisher Introduces Sequential Protein/DNA/RNA Extraction Kit
Thermo Fisher Scientific has launched a kit enabling sequential extraction of protein, DNA, and RNA from a single sample, supporting multi-omics cancer research and downstream mass spectrometry and sequencing applications.
Read More
New England Biolabs Releases Magnetic Bead Kit for Cell-Free DNA Extraction
The automation-compatible system works with plasma, serum, urine and cerebrospinal fluid samples from 1 ml to 4 ml input volumes.
Read More
Watchmaker Genomics Licenses CRISPR Technology to Improve DNA Sequencing Efficiency
The company plans to use CRISPR-Cas9 as a binding tool to address bottlenecks in next-generation sequencing workflows.
Read More
Flow Cytometry Blood Test for Myeloma MRD Detection Launches
The test offers sensitivity comparable to next-generation sequencing methods while using noninvasive blood specimens instead of bone marrow aspirates.
Read More
New Standards Issued for Liquid Biopsy Cancer Recurrence Tests
The BLOODPAC Consortium has released new analytical validation standards for liquid biopsy MRD tests, offering industry-wide protocols for tumor-informed ctDNA assay development, as detailed in JCO Precision Oncology.
Read More
New Method Shows Superior Sensitivity in Liquid Biopsy Testing
Bridge Capture, a targeted NGS method, showed higher sensitivity for detecting rare ctDNA variants than two leading liquid biopsy assays, according to research in The Journal of Molecular Diagnostics.
Read More
Whole-Genome Sequencing Algorithm Shows Promise for PARP Inhibitor Selection
Weill Cornell Medicine researchers report a whole-genome sequencing algorithm may identify more patients for PARP inhibitor cancer therapies than current commercial tests, according to a study in Communications Medicine.
Read More